Frankfurt
30.04.26 | 08:07
3,520 Euro
-2,22 % -0,080
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | AVITA Medical, Inc. - 8-K, Current Report | 21 | SEC Filings | ||
| Do | AVITA MEDICAL INC.: AVITA Medical Names Cary Vance as Chief Executive Officer | - | ASX | ||
| Do | AVITA Medical appoints Cary Vance as permanent CEO | 3 | Seeking Alpha | ||
| Do | AVITA Medical Promotes Interim CEO Cary Vance To CEO | 3 | RTTNews | ||
| Do | AVITA Medical names Cary Vance as permanent CEO | 2 | Investing.com | ||
| Do | AVITA Medical ernennt Cary Vance zum CEO | 3 | Investing.com Deutsch | ||
| AVITA MEDICAL Aktie jetzt für 0€ handeln | |||||
| Do | AVITA Medical Names Cary Vance as Chief Executive Officer | 440 | GlobeNewswire (Europe) | Board appoints Cary Vance as President and Chief Executive Officer Follows successful interim tenure and thorough search process by the Board Jan Stern Reed elected as Chair of the AVITA Medical Board... ► Artikel lesen | |
| Mi | AVITA MEDICAL INC.: AVITA Secures Australia & NZ Clearance for RECELL GO | - | ASX | ||
| Mi | AVITA Medical gains regulatory clearance for RECELL GO in Australia | 1 | Investing.com | ||
| 23.04. | AVITA MEDICAL INC.: AVITA to Announce First Quarter 2026 Financial Results | 1 | ASX | ||
| 23.04. | AVITA Medical to Announce First Quarter 2026 Financial Results | 1 | GlobeNewswire (USA) | ||
| 22.04. | AVITA MEDICAL INC.: Notice of Annual General Meeting/Proxy Form | - | ASX | ||
| 16.04. | AVITA MEDICAL INC.: AVITA KOL Investor Webinar Presentation on Cohealyx | - | ASX | ||
| 16.04. | AVITA MEDICAL INC.: AVITA Founder Fiona Wood recognized by ABA | - | ASX | ||
| 15.04. | AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association | 1 | GlobeNewswire (USA) | ||
| 15.04. | Daily Special: Hiremii, Immutep, AVITA Medical, Southern Palladium | 10 | Finance News Network | ||
| 15.04. | AVITA Medical Reports Accelerating Grafting Times in Positive Interim Results for Cohealyx-I Study | 1 | smallcaps.com.au | ||
| 14.04. | AVITA MEDICAL INC.: AVITA Announces Positive Interim Results from Cohealyx study | - | ASX | ||
| 14.04. | AVITA Medical rises as Cohealyx halves time to skin grafting | 2 | Seeking Alpha | ||
| 14.04. | AVITA Medical Announces Positive Interim Results from Cohealyx Study Demonstrating Accelerated Time to Skin Grafting | 212 | GlobeNewswire (Europe) | Mean time to graft reduced to 13.6 days vs. 33.2 days real-world benchmark (~20 day reduction)Median time to graft of 11 days, with grafting as early as 5 daysStudy ongoing with full dataset expected... ► Artikel lesen |
1 2 3 4 5 Weiter >>
104 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,260 | +2,07 % | Eckert&Ziegler vor kritischer Marke: Droht jetzt der nächste große Absturz? - Die Fakten auf einen Blick | ||
| UNITEDHEALTH | 315,60 | -0,06 % | Aktien New York Schluss: KI-Aktien belasten Nasdaq - Keine Kauflaune vor Fed | NEW YORK (dpa-AFX) - Fallende Kurse von Aktien aus dem Umfeld der Künstlichen Intelligenz (KI) haben am Dienstag die technologielastige Börse Nasdaq belastet. Für den Auswahlindex Nasdaq 100 ging es... ► Artikel lesen | |
| ROKU | 99,00 | -0,32 % | Roku Japanese Gin präsentiert limitierte Noryo Tea Edition / Inspiriert von japanischer Tradition und den unverwechselbaren Pflanzenextrakten von Sencha- und Gyokuro-Grüntee | Frankfurt am Main (ots) - Roku Japanese Gin, der authentische japanische Craft-Gin aus dem Hause Suntory, präsentiert die Markteinführung der Roku Gin Noryo Tea Edition, einer limitierten Sommeredition... ► Artikel lesen | |
| MCKESSON | 694,20 | -0,06 % | William Blair Starts McKesson (MCK) at Outperform, Sees Durable Competitive Moat | ||
| SENSEONICS | 5,450 | -3,54 % | Senseonics platziert Kapitalerhöhung über 80 Mio. US-Dollar zu 5 US-Dollar je Aktie | ||
| ELEKTA | 4,960 | -0,32 % | Dividendenbekanntmachungen (05.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERICAN ASSETS TRUST INC US0240131047 0,34 USD 0,2922 EUR ARMSTRONG WORLD INDUSTRIES INC US04247X1028 0,339 USD 0,2914 EUR ASSOCIATED... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 52,55 | +9,39 % | BrightSpring mischt einen Milliardenmarkt auf | Auf den ersten Blick ist das Geschäft von BrightSpring margenschwach und wenig attraktiv. Doch gerade das eröffnet enorme Chancen für Skalierung und Konsolidierung Den vollständigen Artikel lesen ... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,260 | -10,12 % | Alignment Healthcare forecasts $138M-$163M adjusted EBITDA for 2026 as membership outlook rises to 294,000-299,000 | ||
| HEARTFLOW | 28,670 | -3,66 % | Heartflow, Inc.: Heartflow Files Patent Infringement Lawsuit Against Cleerly | MOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,530 | -0,53 % | S&P Dow Jones Indices: LifeStance Health Group Set to Join S&P SmallCap 600 | NEW YORK, April 27, 2026 /PRNewswire/ -- LifeStance Health Group Inc. (NASD: LFST) will replace Golden Entertainment Inc (NASD: GDEN) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PROGYNY | 18,610 | +0,16 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,850 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen | |
| BILLIONTOONE | 77,70 | +3,53 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 24,630 | +2,41 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GENEDX | 65,36 | +3,93 % | Will Robust Exome and Genome Revenues Lift GeneDx's Q1 Earnings? |
Das Unternehmen AVITA MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -2,22 % bei einem Aktienkurs von 3,520 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AVITA MEDICAL INC finden Sie auf Wallstreet Online.